Arthritis Foundation

FDA Warns of Celebrex Heart Risk

WASHINGTON — The Food and Drug Administration on Friday warned physicians to consider alternatives to the popular arthritis drug Celebrex because of new evidence that, like the similar drug Vioxx, removed from the market in September, it doubles the chances of heart attacks and strokes.

The federal agency said it may soon take other actions, including requiring stronger warnings, or even blocking the drug from sale. The statements call into question the future of the widely used class of painkilling drug called Cox-2 inhibitors.

The FDA warning came just hours after Celebrex manufacturer Pfizer Inc. issued a statement saying that a study of the drug's efficacy as a cancer...

EDITION: California | U.S. & World